Dr. Todd Singleton, nationally acclaimed chiropractic physician, introduces an innovative approach to addressing neuropathy, a condition resulting in nerve damage and excruciating pain. This ...

Results showed 94.4% of study participants demonstrated an improvement in functional disability. The Food and Drug Administration (FDA) has approved Gammagard Liquid ® (immune globulin infusion 10% ...

PHOENIX -- A subcutaneous infusion of efgartigimod cut the risk of relapse in patients with a rare but serious immune-mediated neuropathy, according to the phase II ADHERE trial. Patients with ...

The approval was based on data from a study that compared 2 different maintenance dosages of Panzyga in 142 adults with CIDP. The Food and Drug Administration (FDA) has approved Panzyga ® (immune ...

Prolonged, often disabling, small-fiber neuropathy in long COVID may be caused by a defective immune response, a small longitudinal study suggested. Peripheral neuropathy was identified in 59% of 17 ...

Patients suffering from so-called immune-mediated neuropathies frequently have a long medical record. As there are no diagnostic tests available to reliably diagnose the disease, the diagnosis is ...

Small fiber neuropathy occurs as a result of damage to the small fibers of the peripheral nervous system. Damage to the peripheral nervous system that affects the small fibers can cause burning pain ...

Femoral neuropathy, also called femoral nerve dysfunction, is one possible cause of movement and sensation problems in the legs. Femoral neuropathy occurs when something affects the femoral nerve, ...